Induction of nitric oxide synthase by lipopolysaccharide and its inhibition by auranofin in RAW 264.7 cells

European Journal of Pharmacology

Volumn 338, Issue 2, 1997, Pages 151-158

  Yamashita, Masamichi ^a   Niki, Hisae ^a   Yamada, Masateru ^a   Mue, Suetsugu ^b   Ohuchi, Kazuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Japan   (Japan)

Author keywords

Auronofin; Aurothioglucose; Aurothiomalate; Lipopolysaccharide; Nitric oxide (NO); Nitric oxide (NO) synthase inducible; RAW 264.7 cell

Indexed keywords

AURANOFIN; AUROTHIOGLUCOSE; AUROTHIOMALATE; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; ENZYME INHIBITION; IMMUNOBLOTTING; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0030721509     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)81943-7     Document Type: Article

References (62)

1. Bogdan C., Vodovotz Y., Paik J., Xie Q.W., Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leuk. Biol. 55:1994;227-233.
2. Bogle R.G., Vallance P. Functional effects of econazole on inducible nitric oxide synthase: production of a calmodulin-dependent enzyme. Br. J. Pharmacol. 117:1996;1053-1058.
3. Bondeson J., Sundler R. Auranofin inhibits the induction of interleukin 1β and tumor necrosis factor α mRNA in macrophages. Biochem. Pharmacol. 50:1995;1753-1759.
4. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:1990;682-685.
6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
7. Cox G.W., Melillo G., Chattopadhyay U., Mullet D., Fertel R.H., Varesio L. Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediates IFN-γ plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol. 149:1992;3290-3296.
8. Davis P., Johnston C., Miller C.L., Wong K. Effects of gold compounds on the function of phagocytic cells: II. Inhibition of superoxide radical generation by tripeptide-activated polymorphonuclear leukocytes. Arthritis Rheum. 26:1983;82-86.
9. Deng W., Thiel B., Tannenbaum C.S., Hamilton T.A., Stuehr D.J. Synergistic cooperation between T-cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages. J. Immunol. 151:1993;322-329.
10. DiMartino M.J., Walz D.T. Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. Inflammation. 2:1977;131-142.
11. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:1988;2407-2412.
12. Ding A., Nathan C.F., Graycar J., Derynck R., Stuehr D.J., Srimal S. Macrophage deactivating factor and transforming growth factors-β1, -β2 and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ J. Immunol. 145:1990;940-944.
13. Drapier J.C., Wietzerbin J., Hibbs J.B. Jr. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 18:1988;1587-1592.
14. Elmgreen J., Ahnfelt-Ronne I., Nielsen O.H. Inhibition of human neutrophils by auranofin: chemotaxis and metabolism of arachidonate via the 5-lipoxygenase pathway. Ann. Rhem. Dis. 48:1989;134-138.
15. Farrell A.J., Blake D.R., Palmer R.M., Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51:1992;1219-1222.
16. Finkelstein A.E., Roisman F.R., Walz D.T. Effect of auranofin, a new antiarthritic agent, on immune complex-induced release of lysosomal enzymes from human leukocytes. Inflammation. 2:1977;143-150.
17. Gazzinelli R.T., Oswald I.P., James S.L., Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol. 148:1992;1792-1796.
18. 15N ]nitrate in biological fluids Anal. Biochem. 126:1982;131-138.
19. Hafstrom I., Uden A.M., Palmblad J. Modulation of neutrophil functions by auranofin. Studies on effects in vitro and in rheumatoid arthritis patients. Scand. J. Rheumatol. 12:1983;97-105.
20. Hall T.J., Jeker H., Nyugen H., Schaeublin M. Gold salts inhibit osteoclastic bone resorption in vitro. Inflamm. Res. 45:1996;230-233.
21. 4 formation by human polymorphonuclear leukocytes. Biochem. Pharmacol. 36:1987;1475-1481.
22. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S.I., Kimura T., Green S.J., Mak T.W., Taniguchi T., Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
23. Kirk S.J., Regan M.C., Barbul A. Cloned murine T-lymphocytes synthesize a molecule with the biological characteristics of nitric oxide. Biochem. Biophys. Res. Commun. 173:1990;660-665.
24. Kolb H., Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol. Today. 13:1992;157-160.
25. Kunz D., Walker G., Pfeilschifter J. Dexamethasone differentially affects interleukin 1β- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells. Biochem. J. 304:1994;337-340.
26. Kunz D., Walker G., Eberhardt W., Pfeilschifter J. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1β-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl. Acad. Sci. USA. 93:1996;255-259.
27. Lewis A.J., Carlson R.P., Chang J., DeLustro F. Effect of gold salts, D-penicillamine and benoxaprofen on type II collagen-induced arthritis in rats. Agents Actions. 14:1984;707-714.
28. h1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21:1991;2489-2494.
29. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 90:1993;9730-9734.
30. Martin E., Nathan C., Xie Q.W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:1994;977-984.
31. Melillo G., Cox G.W., Radzioch D., Varesio L. Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages. J. Immunol. 150:1993;4031-4040.
32. Melillo G., Cox G.W., Biragyn A., Sheffler L.A., Varesio L. Regulation of nitric-oxide synthase mRNA expression by interferon-γ and picolinic acid. J. Biol. Chem. 269:1994;8128-8133.
33. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
34. Mulligan M.S., Hevel J.M., Marletta M.A., Ward P.A. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci. USA. 88:1991;6338-6342.
35. Nadeau K.C., Azuma H., Tilney N.L. Sequential cytokine dynamics in chronic rejection of rat renal allografts: Role for cytokines RANTES and MCP-1. Proc. Natl. Acad. Sci. USA. 92:1995;8729-8733.
36. Nunokawa Y., Oikawa S., Tanaka S. Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-κB dependent mechanism. Biochem. Biophys. Res. Commun. 223:1996;347-352.
37. Oswald I.P., Gazzinelli R.T., Sher A., James S.L. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J. Immunol. 148:1992;3578-3582.
38. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
39. Palmer R.M., Andrews T., Foxwell N.A., Moncada S. Glucocorticoids do not affect the induction of a novel calcium-dependent nitric oxide synthase in rabbit chondrocytes. Biochem. Biophys. Res. Commun. 188:1992;209-215.
40. Peters-Golden M., Shelly C. Inhibition of alveolar macrophage 5-lipoxygenase metabolism by auranofin. Biochem. Pharmacol. 38:1989;1589-1595.
41. 2 inhibits interleukin 1β- and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 175:1991;372-379.
42. Raschke W.C., Baird S., Ralph P., Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell. 15:1978;261-267.
43. Robbins M., McKinney M. Transcriptional regulation of neuromodulin (GAP-43) in mouse neuroblastoma clone NIE-115 as evaluated by the RT/PCR method. Mol. Brain Res. 13:1992;83-92.
44. Salter M., Knowles R.G., Moncada S. Widespread tissue distribution, species distribution and changes in activity of calcium-dependent and calcium-independent nitric oxide synthase. FEBS Lett. 291:1991;145-149.
45. Salvemini D., Masini E., Anggard E., Mannaioni P.F., Vane J. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem. Biophys. Res. Commun. 169:1990;596-601.
46. Scheinberg M.A., Santos L.M., Finkelstein A.E. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes. J. Rheumatol. 9:1982;366-369.
47. Sheffler L.A., Wink D.A., Melillo G., Cox G.W. Exogenous nitric oxide regulates IFN-γ plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages. J. Immunol. 155:1995;886-894.
48. Stadler J., Stefanovic-Racic M., Billiar T.R., Curran R.D., McIntyre L.A., Georgescu H.I., Simmons R.L., Evans C.H. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol. 147:1991;3915-3920.
49. Stefanovic-Racic M., Stadler J., Georgescue H.I., Evans C.H. Nitric oxide synthesis and its regulation by rabbit synoviocytes. J. Rheumatol. 21:1994;1892-1898.
50. Ueki Y., Miyake S., Tominaga Y., Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol. 23:1996;230-236.
51. Vodovotz Y., Bogdan C., Paik J., Xie Q.W., Nathan C.F. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β J. Exp. Med. 178:1993;605-613.
52. Vodovotz Y., Kwon N.S., Pospischil M., Manning J., Paik J., Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-γ and bacterial lipopolysaccharide. J. Immunol. 152:1994;4110-4118.
53. Wang C., Smith R.L. Lowry determination of protein in the presence of Triton X-100. Anal. Biochem. 63:1975;414-417.
54. Wang M.H., Cox G.W., Yoshimura T., Sheffler L.A., Skeel A., Leonard E.J. Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin- or cytokine-stimulated mouse macrophages. J. Biol. Chem. 269:1994;14027-14031.
55. Ward J.R., Williams H.J., Egger M.J., Reading J.C., Boyce E., Altz-Smith M., Samuelson C.O. Jr., Willkens R.F., Solsky M.A., Hayes S.P., Blocka K.L., Weinstein A., Meenan R.F., Guttadauria M., Kaplan S.B., Klippel J. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis: A controlled clinical trial. Arthritis Rheum. 26:1983;1303-1315.
56. Wenger M.E., Alexander S., Bland J.H., Blechman W.J. Auranofin versus placebo in the treatment of rheumatoid arthritis. Am. J. Med. 75:1983;123-127.
57. Wright C.D., Mulsch A., Busse R., Osswald H. Generation of nitric oxide by human neutrophils. Biochem. Biophys. Res. Commun. 160:1989;813-819.
58. Xie Q.W., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1993;1779-1784.
59. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
60. 2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages. J. Pharmacol. Exp. Ther. 281:1997;1005-1012.
61. 2 production by rat peritoneal macrophages. Eur. J. Pharmacol. 325:1997;221-227.
62. Yang J.P., Merin J.P., Nakano T., Kato T., Kitade Y., Okamoto T. Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro. FEBS Lett. 361:1995;89-96.